Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma-Reference-Cited by-同舟云学术

Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma

Published:1997 Issue: Volume:8 Page:S67-S70
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Meerwaldt J.H.,Carde P.,Somers R.,Thomas J.,Kluin-Nelemans J.C.,Bron D.,Noordijk E.M.,Cosset J.M.,Bijnens L.,Teodorovic I.,Hagenbeek A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/8/suppl_1/S67/6680842/8-suppl_1-S67.pdf

Reference15 articles.

1. The m-BACOD combination chemotherapy regimen in large-cell lymphoma: Analysis of the completed trial and comparison with the M-BACOD regimen;Shipp;J Clin Oncol,1990

2. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma;Klimo;Ann Intern Med,1985

3. Superiority of Pro-MACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: Results of a prospective randomized trial;Longo;J Clin Oncol,1991

4. LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma;Coiffier;J Clin Oncol,1989

5. Comparison of second generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin’s lymphoma;Gordon;N Engl J Med,1992

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma;Cancers;2021-12-09

2. Late Non-Neoplastic Events in Patients with Aggressive Non-Hodgkin's Lymphoma in Four Randomized European Organisation for Research and Treatment of Cancer Trials;Clinical Lymphoma and Myeloma;2005-09

3. Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin’s lymphoma in three randomised EORTC trials;European Journal of Cancer;2004-03

4. CHOP versus MACOP-B in aggressive lymphoma - a Nordic Lymphoma Group randomised trial;Annals of Oncology;1999-09

5. Combined modality treatment is the treatment of choice for stage I/IE intermediate and high grade non-Hodgkin's lymphomas;Radiotherapy and Oncology;1998-10